GRP
ORMP icon

Global Retirement Partners’s Oramed Pharmaceuticals ORMP Stock Holding History

Global Retirement Partners’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$257 – 3601
2024
Q2 		$257 Hold
100
– – ﹤0.01% 3393
2024
Q1 		$292 Hold
100
– – ﹤0.01% 3222
2023
Q4 		$228 Buy
+100
New +$214 ﹤0.01% 3212
2023
Q2 		– Sell
-125
Closed -$346 – 3234
2023
Q1 		$346 Hold
125
– – ﹤0.01% 3003
2022
Q4 		$1.5K Hold
125
– – ﹤0.01% 2462
2022
Q3 		$1K Hold
125
– – ﹤0.01% 2538
2022
Q2 		$1K Hold
125
– – ﹤0.01% 2509
2022
Q1 		$1K Hold
125
– – ﹤0.01% 2473
2021
Q4 		$2K Hold
125
– – ﹤0.01% 226
2021
Q3 		$3K Hold
125
– – ﹤0.01% 1764
2021
Q2 		$2K Hold
125
– – ﹤0.01% 1742
2021
Q1 		$1K Buy
+125
New +$1.03K ﹤0.01% 1728

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Global Retirement Partners's ORMP Position: Q3 2024 in Review

Global Retirement Partners sold out of Oramed Pharmaceuticals (ORMP) in Q3 2024, closing a stake of 100 shares — an estimated $257 sold.

Global Retirement Partners first reported a position in ORMP in Q1 2021 and held it in 12 quarters. The position peaked at $3K in Q3 2021. 55 funds tracked by Wall St. Rank hold ORMP as of Q3 2024.

  • Global Retirement Partners reported no remaining Oramed Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Global Retirement Partners sold 100 Oramed Pharmaceuticals shares in Q3 2024, an estimated $257.
  • Global Retirement Partners first reported a position in Oramed Pharmaceuticals in Q1 2021 and held it in 12 quarters.
  • Global Retirement Partners's Oramed Pharmaceuticals position peaked at $3K in Q3 2021.
  • 55 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2024.

Based on Global Retirement Partners's 13F filing for Q3 2024, filed 16 Oct 2024.